Opinion What increasing impact factors mean for the RCPharm research journals The latest impact metrics from Clarivate and Scopus have been published, showing a positive trend for the Royal College of Pharmacy research journals.…Published: 5 August 2026
News Incretin-based weight-loss drugs should not be deliberately continued in pregnancy, consensus guidelines state The guidelines have been drawn up by a multidisciplinary group of experts following a systematic scoping review.…Published: 4 August 2026
Opinion How pharmacists can transform prescribing safety in psychiatry Medication errors disproportionately affect patients with mental illness but pharmacists’ expertise in psychopharmacology could help tailor prescribing to better meet individual patient needs.…Published: 4 August 2026
News Delivery of 90,000 meningitis B vaccinations for young people prompts call for annual campaign During the first week of the NHS meningococcal B disease vaccination service, more than 8,200 participating pharmacies received around 135,000 bookings.…Published: 4 August 2026
News Digital systems in general practice could reduce medication errors Across the 74 randomised controlled trials under review, the most frequent intervention component was clinical decision support systems, which was mentioned in 59 papers.…Published: 3 August 2026
News Once-weekly HIV pill performs as well as daily treatment in phase III study Researchers found that a once-weekly tablet combining islatravir and lenacapavir performed as well as the once-daily bictegravir–emtricitabine–tenofovir alafenamide regimen.…Published: 3 August 2026
News Clive Edwards (1944–2026)On 18 July 2026, Clive Edwards, aged 82 years, of Crook, County Durham. Mr Edwards registered with the College in 1967.…Published: 3 August 2026
Opinion Virtual reality holds the promise of filling medicines manufacturing workforce gaps Will virtual reality technology enable the UK to meet the demands of training in the pharmaceutical industry and medicines manufacturing.…Published: 3 August 2026
News NICE recommends heart drug aficamten with simultaneous MHRA approval The National Institute for Health and Care Excellence said that aficamten is likely to be as effective as mavacamten in treating obstructive hypertrophic cardiomyopathy, with “fewer monitoring scans to find the right dose”.…Published: 3 August 2026
News ICBs funded for independent prescribing implementation NHS England has published three documents relating to community pharmacist prescribing in 2026/2027.…Published: 31 July 2026
